Overview
Hot Topics in PAH: What We’ve Learned in the Past Year
PAH Hot Topics
Click the "View Activity" button to view this activity.
View ActivityCME/CE is no longer available for this activity
How can clinicians improve early detection of PAH? What are some practical strategies for managing PAH patients in today’s world? What recent data support current treatment strategies, and what are emerging therapeutic options? This 30-minute multimedia Q&A touchpoint “Hot Topics” CME activity features leading pulmonology expert Dan Schuller, MD, from Texas Tech University Health Sciences Center who discusses the latest data and recommendations, along with his insights for applying this information in clinical practice. This activity features engaging images, charts, and short video snippets. Dive into recommendations from the 6th World Symposium on Pulmonary Hypertension, new risk assessment tools, and more!
This activity is intended for pulmonologists, cardiologists, cardiopulmonologists, and other healthcare providers (MDs, PAs, and NPs) interested in treating patients with PAH.
The diagnosis of PAH is challenging, and diagnostic delays are common, leading to poorer patient outcomes. In addition, treatment selection for patients with PAH is complex when considering the number of therapies, combinations of different therapies, and recent updates to treatment guidelines. Clinicians require ongoing education on diagnostic algorithms, patient populations appropriate for screening, risk assessment methods to guide patient management, and recent clinical trial data to support treatment selection. Clinicians will also learn about timely real-world aspects of patient care, including management of PAH patients during the COVID-19 pandemic. Upon completion of this activity, clinicians will be better able to apply appropriate diagnostic/screening methods, risk assessment tools, recent clinical data, and expert insights on real-world best practices to enhance their recognition and management of PAH in clinical practice.
Upon completion of this activity, participants will be able to:
• Discuss current best practices and recommendations for PAH screening, diagnosis, risk assessment, and multidisciplinary real-world care
• Review recent clinical data that inform the safety and efficacy of individual PAH treatments and combination therapies
• List emerging clinical research initiatives in PAH and their potential impact on both current and future patient care plans
• Discuss current best practices and recommendations for PAH screening, diagnosis, risk assessment, and multidisciplinary real-world care
• Review recent clinical data that inform the safety and efficacy of individual PAH treatments and combination therapies
• List emerging clinical research initiatives in PAH and their potential impact on both current and future patient care plans
• Screening and diagnosis of PAH
• Evolution of risk assessment in treatment selection
• Recent clinical data and approvals
• Real-world management of PAH
• Emerging therapies
• Evolution of risk assessment in treatment selection
• Recent clinical data and approvals
• Real-world management of PAH
• Emerging therapies
Sponsored by the Academy for Continued Healthcare Learning (ACHL).
Supported by an educational grant from Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson.
1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Flash Player 12.0 (or higher). Click here to download Adobe Flash Player for free.
5. Adobe Reader to print certificate. Click here to download Adobe Reader for free.
6. Allow ActiveX controls to run on your computer: If the yellow strip appears on the top of your web browser while running the Webcast, right click on it and select Allow blocked contents to run.
Turn the Pop-up blocker off: On the Tools menu, point to Pop-up Blocker, and then click Turn Off Pop-up Blocker
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Flash Player 12.0 (or higher). Click here to download Adobe Flash Player for free.
5. Adobe Reader to print certificate. Click here to download Adobe Reader for free.
6. Allow ActiveX controls to run on your computer: If the yellow strip appears on the top of your web browser while running the Webcast, right click on it and select Allow blocked contents to run.
Turn the Pop-up blocker off: On the Tools menu, point to Pop-up Blocker, and then click Turn Off Pop-up Blocker
Dan Schuller, MD
Professor and Chair
Department of Internal Medicine – Transmountain
Texas Tech University Health Sciences Center
Paul L. Foster School of Medicine
El Paso, TX
Professor and Chair
Department of Internal Medicine – Transmountain
Texas Tech University Health Sciences Center
Paul L. Foster School of Medicine
El Paso, TX
The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in an accredited continuing education activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been mitigated prior to this activity.
Dan Schuller, MD, has no financial relationships to disclose.
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: Rodatristat ethyl, CS1, seralutinib, AV-101, treprostinil palmitil inhalation powder, radiofrequency ablation catheter, treprostinil DPI, and sotatercept
ACHL staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
The content for this activity was developed independently of the commercial supporter. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor.
This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.
This activity will take approximately 30-minutes to complete. To receive credit, participants are required to complete the pretest, view the online activity and complete the posttest and evaluation. To receive credit, 66% must be achieved on the posttest. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.
For questions, contact Michelle Forcier at mforcier@achlcme.org.
The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Academy for Continued Healthcare Learning designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
(NOTE: Nurse practitioners may participate in this educational activity and earn a certificate of completing as AANP accepts AMA PRA Category 1 Credits™ through its reciprocity agreements.)
